Feedback / Questions
Oncorine (recombinant human adenovirus type 5) - Mergen Ltd.
AiRuiKa (camrelizumab) - HLB Bio Group
http://clinicaltrials.gov/ct2/show/NCT06196671
Aug 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next